查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842192

北美医疗人工智慧市场：市场规模、份额和趋势分析（按组件、应用、最终用途、技术和国家划分），细分市场预测（2025-2033 年）

North America Artificial Intelligence In Healthcare Market Size, Share, And Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Application, By End-use, By Technology, By Country, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

北美医疗保健人工智慧市场概览

预计到 2024 年，北美医疗保健人工智慧 (AI) 市场价值将达到 146.6 亿美元，预计到 2033 年将达到 2,508.1 亿美元，2025 年至 2033 年的复合年增长率为 37.17%。

数位医疗基础设施的快速扩张、远端医疗和远距会诊的日益普及、政府投资的增加以及该国的人工智慧（AI）策略都是推动市场成长的因素。

强大的医疗基础设施和主要企业在研发方面的巨额投入将推动北美市场的成长。 IBM、GE医疗、微软和西门子赫特海姆股份公司等产业领导者的存在，确保了人工智慧平台、软体和解决方案的持续创新。例如，飞利浦于2025年8月宣布计划在美国投资超过1.5亿美元用于製造和研发，扩建其位于宾州的人工智慧超音波系统生产基地和位于明尼苏达州普利茅斯的影像导引治疗中心。

此外，慢性病发病率上升、人口老化以及医疗成本不断攀升，正促使医疗系统转向人工智慧寻求可扩展的解决方案。人工智慧能够进行预测分析，从而预测疾病进展、优化治疗方案并减少不必要的住院。人工智慧支援的基于价值的医疗模式能够提高医疗品质和成本效益，为支付方、医疗服务提供者和患者带来可衡量的益处。

此外，诸如新产品发布、伙伴关係、联盟和併购等战略倡议的增加，预计将推动人工智慧在诊断成像、慢性病管理和临床决策支援等领域实现可扩展的解决方案，从而进一步促进市场发展。这些伙伴关係透过共用专业知识、资源和检验框架，确保了持续创新。例如，2025年6月，加拿大人工智慧公司Cohere与美国Ensemble Health Partners合作，推出了一款人工智慧医疗保健代理，用于自动化处理诸如索赔被拒绝申诉、收入週期管理（RCM）改进和患者体验等行政任务。此外，人工智慧Start-Ups和数位健康平台的激增将促进生态系统的发展和多元化创新。因此，这种协作生态系统是推动该地区人工智慧在各种医疗保健应用领域普及的强大动力。

目录

第一章 分析方法和范围

第二章执行摘要

3. 北美医疗保健人工智慧市场：驱动因素、趋势和范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 医疗保健领域的人工智慧市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

4. 北美医疗保健人工智慧 (AI) 市场：按组件分類的估算和趋势分析

  • 北美医疗保健人工智慧市场：按组件分類的变化分析
  • 北美医疗保健人工智慧市场规模及趋势分析（按组件划分）（2021-2033 年）
    • 软体解决方案
    • 硬体
    • 服务

5. 北美医疗保健人工智慧 (AI) 市场：按应用领域分類的估算和趋势分析

  • 北美医疗保健人工智慧市场：按应用领域分類的变化分析
  • 北美医疗人工智慧市场规模及应用趋势分析（2021-2033）
    • 机器人辅助手术
    • 虚拟助手
    • 管理工作流程助手
    • 互联医疗设备
    • 影像诊断
    • 临床试验
    • 诈欺侦测
    • 网路安全
    • 减少剂量误差
    • 精准医疗
    • 药物发现与开发
    • 生活方式管理和远端患者监护
    • 穿戴式装置
    • 其他的

6. 北美医疗保健人工智慧 (AI) 市场：按技术分類的估算和趋势分析

  • 北美医疗保健人工智慧市场：按技术分類的变化分析
  • 北美医疗保健人工智慧市场规模及技术趋势分析（2021-2033）
    • 机器学习
    • 自然语言处理 (NLP)
    • 电脑视觉
    • 情境感知感知计算

7. 北美医疗保健人工智慧 (AI) 市场：按最终用途分類的估算和趋势分析

  • 北美医疗保健人工智慧市场：按最终用途分類的变化分析
  • 北美医疗保健人工智慧市场规模及趋势分析（按最终用途划分）（2021-2033 年）
    • 医院和医疗机构
    • 医疗保健支付方
    • 製药和生物技术公司
    • 病人
    • 其他的

8. 北美医疗保健领域人工智慧 (AI) 市场：国别估算和趋势分析（按组件、应用、技术和最终用途划分）

  • 北美区域市场概述
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第九章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • Competitive Landscape
    • 微软
    • IBM
    • 英伟达公司
    • 英特尔公司
    • GE医疗
    • Medtronic
    • Oracle
    • Google
    • 艾克比尔
    • 西门子医疗股份公司
    • 飞利浦公司
    • Tempus AI
Product Code: GVR-4-68040-741-4

North America AI In Healthcare Market Summary

The North America artificial intelligence in healthcare market size was estimated at USD 14.66 billion in 2024 and is projected to reach USD 250.81 billion by 2033, growing at a CAGR of 37.17% from 2025 to 2033. Rapid expansion of digital health infrastructure, growing adoption of telemedicine and remote care, and increasing government investments, coupled with national artificial intelligence (AI) strategies, are factors contributing to market growth.

Robust healthcare infrastructure and substantial R&D investments by key players catalyze market growth in North America. The presence of industry leaders such as IBM, GE Healthcare, Microsoft, and Siemens Healthineers AG, among others, ensures continued innovation in AI platforms, software, and solutions. For instance, in August 2025, Philips announced plans to invest over USD 150 million in U.S. manufacturing and R&D, expanding its Pennsylvania facility that produces AI-enabled ultrasound systems and its Image Guided Therapy facility in Plymouth, Minnesota.

Moreover, the rising prevalence of chronic diseases, a growing geriatric population, and increasing healthcare costs push healthcare systems to AI for scalable solutions. AI enables predictive analytics to forecast disease progression, optimize treatment plans, and reduce unnecessary hospitalizations. Value-based care models supported by AI improve care quality and cost-effectiveness, providing measurable benefits to payers, providers, and patients.

Furthermore, increasing strategic initiatives such as new product launches, partnerships, collaborations, and mergers and acquisitions, leading to scalable AI solutions in imaging, chronic disease management, and clinical decision support, are expected to propel the market further. These partnerships ensure continuous innovation through shared expertise, resources, and validation frameworks. For instance, in June 2025, Cohere, a Canadian AI firm, in partnership with the U.S.-based Ensemble Health Partners, launched its AI healthcare agents to automate administrative tasks like appealing insurance claim denials, improving revenue cycle management (RCM), and patient experience. In addition, the proliferation of AI startups and digital health platforms fosters ecosystem growth and diverse innovation. Thus, such a collaborative ecosystem remains a strong driver of AI deployment across diverse healthcare applications in the region.

North America Artificial Intelligence In Healthcare Market Report Segmentation

This report forecasts revenue growth at the regional and country-levels and provides an analysis of industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the North America Artificial Intelligence (AI) in healthcare market report based on component, application, technology, end-use, and country:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Hardware
    • Processor
    • MPU (memory protection unit)
    • FPGA (Field-programmable gate array)
    • GPU (Graphics processing unit)
    • ASIC (Application-specific integrated circuit)
    • Memory
    • Network
    • Adapter
    • Interconnect
    • Switch
  • Software Solutions
    • AI Platform
    • Application Program Interface (API)
    • Machine Learning Framework
    • AI Solutions
    • On premise
    • Cloud based
  • Services
    • Deployment & Integration
    • Support & Maintenance
    • Others (Consulting, Compliance management)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Robot Assisted Surgery
  • Virtual Assistants
  • Administrative Workflow Assistants
  • Connected Medical devices
  • Medical Imaging & Diagnostics
  • Clinical Trials
  • Fraud Detection
  • Cybersecurity
  • Dosage Error Reduction
  • Precision medicine
  • Drug discovery & development
  • Lifestyle management & remote patient monitoring
  • Wearables
  • Others (Patient engagement)
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning
    • Deep learning
    • Supervised
    • Unsupervised
    • Others (Reinforcement learning, Semi supervised)
  • Natural Language Processing
    • Smart Assistance
    • OCR (Optical Character Recognition)
    • Auto Coding
    • Text analytics
    • Speech analytics
    • Classification and categorization
  • Context-Aware Computing
  • Computer Vision
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Healthcare providers
  • Healthcare payers
  • Pharmaceutical & Biotechnology Companies
  • Patients
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Application Segment
    • 1.2.3. Technology Segment
    • 1.2.4. End Use Segment
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Data Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Artificial Intelligence (AI) in Healthcare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. AI in Healthcare Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. North America Artificial Intelligence (AI) in Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. North America AI in Healthcare Market: Component Movement Analysis
  • 4.2. North America AI in Healthcare Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
    • 4.2.1. Software Solutions
      • 4.2.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.2.1.1.1. AI platform
          • 4.2.1.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.1.1.1.2. Application Program Interface (API)
            • 4.2.1.1.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.1.1.1.3. Machine Learning Framework
            • 4.2.1.1.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.2.1.1.2. AI Solutions
          • 4.2.1.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.1.1.2.2. On premise
            • 4.2.1.1.2.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.1.1.2.3. Cloud based
            • 4.2.1.1.2.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.2.2. Hardware
      • 4.2.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.2.2.1.1. Processor
          • 4.2.2.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.2.1.1.2. MPU (memory protection unit)
            • 4.2.2.1.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.2.1.1.3. FPGA (Field-programmable gate array)
            • 4.2.2.1.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.2.1.1.4. GPU (Graphics processing unit)
            • 4.2.2.1.1.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.2.1.1.5. ASIC (Application-specific integrated circuit)
            • 4.2.2.1.1.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.2.2.1.2. Memory
          • 4.2.2.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.2.2.1.3. Network
          • 4.2.2.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.2.1.3.2. Adapter
            • 4.2.2.1.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.2.1.3.3. Interconnect
            • 4.2.2.1.3.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.2.2.1.3.4. Switch
            • 4.2.2.1.3.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.2.3. Services
      • 4.2.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.2.3.1.1. Deployment & Integration
          • 4.2.3.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.2.3.1.2. Support & Maintenance
          • 4.2.3.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.2.3.1.3. Others (Consulting, Compliance management)
          • 4.2.3.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. North America Artificial Intelligence (AI) in Healthcare Market: Application Estimates & Trend Analysis

  • 5.1. North America AI in Healthcare Market: Application Movement Analysis
  • 5.2. North America AI in Healthcare Market Size & Trend Analyses, by Application, 2021 to 2033 (USD Million)
    • 5.2.1. Robot Assisted Surgery
      • 5.2.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.2. Virtual Assistants
      • 5.2.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.3. Administrative Workflow Assistants
      • 5.2.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.4. Connected Medical Devices
      • 5.2.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.5. Medical Imagining & Diagnosis
      • 5.2.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.6. Clinical Trials
      • 5.2.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.7. Fraud Detection
      • 5.2.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.8. Cybersecurity
      • 5.2.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.9. Dosage Error Reduction
      • 5.2.9.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.10. Precision medicine
      • 5.2.10.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.11. Drug discovery & development
      • 5.2.11.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.12. Lifestyle management & remote patient monitoring
      • 5.2.12.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.13. Wearables
      • 5.2.13.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.2.14. Others
      • 5.2.14.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. North America Artificial Intelligence (AI) in Healthcare Market: Technology Estimates & Trend Analysis

  • 6.1. North America AI in Healthcare Market: Technology Movement Analysis
  • 6.2. North America AI in Healthcare Market Size & Trend Analyses, by Technology, 2021 to 2033 (USD Million)
    • 6.2.1. Machine Learning
      • 6.2.1.1. Market estimates and forecast 2021 to 2033 (USD million)
        • 6.2.1.1.1. Deep learning
          • 6.2.1.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.2.1.1.2. Supervised
          • 6.2.1.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.2.1.1.3. Unsupervised
          • 6.2.1.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.2.1.1.4. Others (Reinforcement learning, Semi supervised)
          • 6.2.1.1.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 6.2.2. NLP
      • 6.2.2.1. Market estimates and forecast 2021 to 2033 (USD million)
        • 6.2.2.1.1. Smart Assistance
          • 6.2.2.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.2.2.1.2. OCR (Optical Character Recognition)
          • 6.2.2.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.2.2.1.3. Auto Coding
          • 6.2.2.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.2.2.1.4. Text analytics
          • 6.2.2.1.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.2.2.1.5. Speech analytics
          • 6.2.2.1.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.2.2.1.6. Classification and categorization
          • 6.2.2.1.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 6.2.3. Computer Vision
      • 6.2.3.1. Market estimates and forecast 2021 to 2033 (USD million)
    • 6.2.4. Context-aware computing
      • 6.2.4.1. Market estimates and forecast 2021 to 2033 (USD million)

Chapter 7. North America Artificial Intelligence (AI) in Healthcare Market: End Use Estimates & Trend Analysis

  • 7.1. North America AI in Healthcare Market: End Use Movement Analysis
  • 7.2. North America AI in Healthcare Market Size & Trend Analyses, By End Use, 2021 to 2033 (USD Million)
    • 7.2.1. Hospitals & Healthcare providers
      • 7.2.1.1. Market estimates and forecast 2021 to 2033 (USD million)
    • 7.2.2. Healthcare payers
      • 7.2.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 7.2.3. Pharmaceutical & Biotechnology Companies
      • 7.2.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 7.2.4. Patients
      • 7.2.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 7.2.5. Others
      • 7.2.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. North America Artificial Intelligence (AI) in Healthcare Market: Country Estimates & Trend Analysis by Component, Applications, Technology & End Use

  • 8.1. North America Regional Market Snapshot
  • 8.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. U.S. market estimates and forecast, 2021-2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Canada market estimates and forecast, 2021-2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Canada market estimates and forecast, 2021-2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Competitive Landscape
    • 9.3.1. Microsoft
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. IBM
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. NVIDIA Corporation
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Intel Corporation
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. GE Healthcare
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Medtronic
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Oracle
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Google
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. IQVIA
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Siemens Healthineers AG
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Koninklijke Philips N.V.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Tempus AI
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America AI in Healthcare Market, By Country, 2021 - 2033 (USD Million)
  • Table 3 North America AI in Healthcare Market, By Components, 2021 - 2033 (USD Million)
  • Table 4 North America AI in Healthcare Market, By Application, 2021 - 2033 (USD Million)
  • Table 5 North America AI in Healthcare Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 North America AI in Healthcare Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 U.S. AI in Healthcare Market, By Components, 2021 - 2033 (USD Million)
  • Table 8 U.S. AI in Healthcare Market, By Application, 2021 - 2033 (USD Million)
  • Table 9 U.S. AI in Healthcare Market, By Technology, 2021 - 2033 (USD Million)
  • Table 10 U.S. AI in Healthcare Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 Canada AI in Healthcare Market, By Components, 2021 - 2033 (USD Million)
  • Table 12 Canada AI in Healthcare Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 Canada AI in Healthcare Market, By Technology, 2021 - 2033 (USD Million)
  • Table 14 Canada AI in Healthcare Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 Mexico AI in Healthcare Market, By Components, 2021 - 2033 (USD Million)
  • Table 16 Mexico AI in Healthcare Market, By Application, 2021 - 2033 (USD Million)
  • Table 17 Mexico AI in Healthcare Market, By Technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico AI in Healthcare Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Strategic Initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 North America AI in healthcare market: market outlook
  • Fig. 10 North America AI in healthcare competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 North America AI in healthcare market driver impact
  • Fig. 16 North America AI in healthcare market restraint impact
  • Fig. 17 North America AI in healthcare market strategic initiatives analysis
  • Fig. 18 North America AI in healthcare market: Components movement analysis
  • Fig. 19 North America AI in healthcare market: Components outlook and key takeaways
  • Fig. 20 Software solutions market estimates and forecast, 2021 - 2033
  • Fig. 21 Hardware management estimates and forecast, 2021 - 2033
  • Fig. 22 Services estimates and forecast, 2021 - 2033
  • Fig. 23 North America AI in healthcare market: Application movement analysis
  • Fig. 24 North America AI in healthcare market: Application outlook and key takeaways
  • Fig. 25 Robot assisted surgery market estimates and forecast, 2021 - 2033
  • Fig. 26 Virtual assistants market estimates and forecast, 2021 - 2033
  • Fig. 27 Administrative workflow assistants market estimates and forecast, 2021 - 2033
  • Fig. 28 Connected medical devices market estimates and forecast, 2021 - 2033
  • Fig. 29 Medical imaging & diagnostics market estimates and forecast, 2021 - 2033
  • Fig. 30 Clinical trials market estimates and forecast, 2021 - 2033
  • Fig. 31 Fraud detection market estimates and forecast, 2021 - 2033
  • Fig. 32 Cybersecurity market estimates and forecast, 2021 - 2033
  • Fig. 33 Dosage error reduction market estimates and forecast, 2021 - 2033
  • Fig. 34 Precision medicine market estimates and forecast, 2021 - 2033
  • Fig. 35 Drug discovery & developments market estimates and forecast, 2021 - 2033
  • Fig. 36 Lifestyle management & remote patient monitoring market estimates and forecast, 2021 - 2033
  • Fig. 37 Wearables market estimates and forecast, 2021 - 2033
  • Fig. 38 Others market estimates and forecast, 2021 - 2033
  • Fig. 39 North America AI in healthcare market: End Use movement analysis
  • Fig. 40 North America AI in healthcare market: End Use outlook and key takeaways
  • Fig. 41 Hospitals & Healthcare providers market estimates and forecast, 2021 - 2033
  • Fig. 42 Healthcare payers market estimates and forecast, 2021 - 2033
  • Fig. 43 Healthcare companies market estimates and forecast, 2021 - 2033
  • Fig. 44 Patients market estimates and forecast, 2021 - 2033
  • Fig. 45 Others market estimates and forecast, 2021 - 2033
  • Fig. 46 North America AI in healthcare market: Technology movement analysis
  • Fig. 47 North America AI in healthcare market: Technology outlook and key takeaways
  • Fig. 48 Machine learning market estimates and forecast, 2021 - 2033
  • Fig. 49 NLP market estimates and forecast, 2021 - 2033
  • Fig. 50 Context-aware computiing market estimates and forecast, 2021 - 2033
  • Fig. 51 Computer vision market estimates and forecast, 2021 - 2033
  • Fig. 52 North America AI in healthcare market: Regional movement analysis
  • Fig. 53 North America AI in healthcare market: Regional outlook and key takeaways
  • Fig. 54 North America market estimates and forecast, 2021 - 2033
  • Fig 55 U.S. market estimates and forecast, 2021 - 2033
  • Fig. 56 Canada market estimates and forecast, 2021 - 2033
  • Fig. 57 Mexico market estimates and forecast, 2021 - 2033